Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (2,080)

Search Parameters:
Keywords = case-fatality

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
30 pages, 4409 KiB  
Article
Accident Impact Prediction Based on a Deep Convolutional and Recurrent Neural Network Model
by Pouyan Sajadi, Mahya Qorbani, Sobhan Moosavi and Erfan Hassannayebi
Urban Sci. 2025, 9(8), 299; https://doi.org/10.3390/urbansci9080299 (registering DOI) - 1 Aug 2025
Abstract
Traffic accidents pose a significant threat to public safety, resulting in numerous fatalities, injuries, and a substantial economic burden each year. The development of predictive models capable of the real-time forecasting of post-accident impact using readily available data can play a crucial role [...] Read more.
Traffic accidents pose a significant threat to public safety, resulting in numerous fatalities, injuries, and a substantial economic burden each year. The development of predictive models capable of the real-time forecasting of post-accident impact using readily available data can play a crucial role in preventing adverse outcomes and enhancing overall safety. However, existing accident predictive models encounter two main challenges: first, a reliance on either costly or non-real-time data, and second, the absence of a comprehensive metric to measure post-accident impact accurately. To address these limitations, this study proposes a deep neural network model known as the cascade model. It leverages readily available real-world data from Los Angeles County to predict post-accident impacts. The model consists of two components: Long Short-Term Memory (LSTM) and a Convolutional Neural Network (CNN). The LSTM model captures temporal patterns, while the CNN extracts patterns from the sparse accident dataset. Furthermore, an external traffic congestion dataset is incorporated to derive a new feature called the “accident impact” factor, which quantifies the influence of an accident on surrounding traffic flow. Extensive experiments were conducted to demonstrate the effectiveness of the proposed hybrid machine learning method in predicting the post-accident impact compared to state-of-the-art baselines. The results reveal a higher precision in predicting minimal impacts (i.e., cases with no reported accidents) and a higher recall in predicting more significant impacts (i.e., cases with reported accidents). Full article
Show Figures

Figure 1

8 pages, 9195 KiB  
Case Report
Fatal Case of Viral Pneumonia Associated with Metapneumovirus Infection in a Patient with a Burdened Medical History
by Parandzem Khachatryan, Naira Karalyan, Hasmik Petunts, Sona Hakobyan, Hranush Avagyan, Zarine Ter-Pogossyan and Zaven Karalyan
Microorganisms 2025, 13(8), 1790; https://doi.org/10.3390/microorganisms13081790 - 31 Jul 2025
Viewed by 39
Abstract
Background: Human metapneumovirus (hMPV) is a respiratory pathogen that causes illness ranging from mild upper respiratory tract infections to severe pneumonia, particularly in individuals with comorbidities. Fatal cases of hMPV-induced hemorrhagic pneumonia are rare and likely under-reported. Diagnosis is often delayed due to [...] Read more.
Background: Human metapneumovirus (hMPV) is a respiratory pathogen that causes illness ranging from mild upper respiratory tract infections to severe pneumonia, particularly in individuals with comorbidities. Fatal cases of hMPV-induced hemorrhagic pneumonia are rare and likely under-reported. Diagnosis is often delayed due to overlapping symptoms with other respiratory viruses and the rapid progression of the disease. Case presentation: We report the case of a 55-year-old man with a complex medical history, including liver cirrhosis and diabetes mellitus, who developed acute viral pneumonia. Initial symptoms appeared three days before a sudden clinical deterioration marked by shortness of breath, hemoptysis, and respiratory failure. A nasopharyngeal swab taken on the third day of illness tested positive for hMPV by qRT-PCR. The patient died the following day. Postmortem molecular testing confirmed hMPV in lung tissue and alveolar contents. Autopsy revealed bilateral hemorrhagic pneumonia with regional lymphadenopathy. Histopathological examination showed alveolar hemorrhage, multinucleated cells, neutrophilic infiltration, activated autophagy in macrophages, and numerous cytoplasmic eosinophilic viral inclusions. Conclusions: This is the first documented case of fatal hMPV pneumonia in Armenia. It highlights the potential severity of hMPV in adults with chronic health conditions and emphasizes the need for timely molecular diagnostics. Postmortem identification of characteristic viral inclusions may serve as a cost-effective histopathological marker of hMPV-associated lung pathology. Full article
(This article belongs to the Section Virology)
Show Figures

Figure 1

11 pages, 393 KiB  
Article
Group A Streptococcal Invasive Infections Among Children in Cyprus
by Maria Koliou, Gavriella Ioannou Vassiliadou, Athina Aristidou, Petros Ladas, Andreas Sergis, Maria Argyrou, Myria Charalambous, Markella Marcou, Maria Alexandrou, Juliana Coelho, Yan Ryan, Androulla Efstratiou and Stella Mazeri
Microorganisms 2025, 13(8), 1783; https://doi.org/10.3390/microorganisms13081783 - 31 Jul 2025
Viewed by 114
Abstract
An increase in invasive group A streptococcal (iGAS) infections among children under 15 years of age was reported in several countries between late 2022 and early 2023. This retrospective study aims to describe the epidemiology and clinical features of iGAS infections in children [...] Read more.
An increase in invasive group A streptococcal (iGAS) infections among children under 15 years of age was reported in several countries between late 2022 and early 2023. This retrospective study aims to describe the epidemiology and clinical features of iGAS infections in children in Cyprus during the same period. Medical records of patients under 16 years old admitted with iGAS infection to the Archbishop Makarios Hospital, the only tertiary paediatric referral centre in Cyprus, between 1 January 2021 and 30 June 2024, were reviewed. Twenty-two cases were identified, of which twenty were classified as confirmed and two as probable. Half of the cases occurred in children aged 0–4 years, and 59% were recorded between December 2022 and April 2023. Scarlet fever was diagnosed in six children, five of whom developed pneumonia and empyema. Streptococcal toxic shock syndrome (STSS) was observed in five patients, resulting in two deaths and one case requiring prolonged extracorporeal membrane oxygenation (ECMO). The overall case fatality rate was 9.1%. Emm 1, belonging to the M1UK clone, was the predominant strain (66.6%). The findings underscore the severity of iGAS infections, particularly in younger children, and highlight the importance of timely diagnosis, appropriate management and continued epidemiological surveillance. Full article
Show Figures

Figure 1

13 pages, 413 KiB  
Article
A Retrospective Cohort Study of Leptospirosis in Crete, Greece
by Petros Ioannou, Maria Pendondgis, Eleni Kampanieri, Stergos Koukias, Maria Gorgomyti, Kyriaki Tryfinopoulou and Diamantis Kofteridis
Trop. Med. Infect. Dis. 2025, 10(8), 209; https://doi.org/10.3390/tropicalmed10080209 - 25 Jul 2025
Viewed by 389
Abstract
Introduction: Leptospirosis is an under-recognized zoonosis that affects both tropical and temperate regions. While it is often associated with exposure to contaminated water or infected animals, its presentation and epidemiology in Mediterranean countries remain incompletely understood. This retrospective cohort study investigates the clinical [...] Read more.
Introduction: Leptospirosis is an under-recognized zoonosis that affects both tropical and temperate regions. While it is often associated with exposure to contaminated water or infected animals, its presentation and epidemiology in Mediterranean countries remain incompletely understood. This retrospective cohort study investigates the clinical and epidemiological profile of leptospirosis in Crete, Greece, a region where data are scarce. Methods: All adult patients with laboratory-confirmed leptospirosis admitted to three major public hospitals in Crete, Greece, between January 2019 and December 2023 were included in the analysis. Diagnosis was made through serologic testing along with compatible clinical symptoms. Results: A total of 17 patients were included. Their median age was 48 years, with a predominance of males (70.6%). Notably, more than half of the patients had no documented exposure to classic risk factors such as rodents or standing water. Clinical presentations were varied but commonly included fever, fatigue, acute kidney injury, and jaundice. Of the patients who underwent imaging, most showed hepatomegaly. The median delay from symptom onset to diagnosis was 11 days, underscoring the diagnostic challenge in non-endemic areas. Ceftriaxone was the most frequently administered antibiotic (76.5%), often in combination with tetracyclines or quinolones. Despite treatment, three patients (17.6%) died, all presenting with severe manifestations such as ARDS, liver failure, or shock. A concerning increase in cases was noted in 2023. Conclusions: Leptospirosis can present with severe and potentially fatal outcomes even in previously healthy individuals and in regions not traditionally considered endemic. The relatively high mortality and disease frequency noted emphasize the importance of maintaining a high index of suspicion. Timely diagnosis and appropriate antimicrobial therapy are essential to improving patient outcomes. Additionally, the need for enhanced public health awareness, diagnostic capacity, and possibly environmental surveillance to control this neglected but impactful disease better, should be emphasized. Full article
(This article belongs to the Special Issue Leptospirosis and One Health)
Show Figures

Figure 1

11 pages, 796 KiB  
Review
Prenatal Rare 16q24.1 Deletion Between Genomics and Epigenetics: A Review
by Valentina Fumini, Romina Bonora, Anna Busciglio, Francesca Cartisano, Paola Celli, Ilaria Gabbiato, Nicola Guercini, Barbara Mancini, Donatella Saccilotto, Anna Zilio and Daniela Zuccarello
Genes 2025, 16(8), 873; https://doi.org/10.3390/genes16080873 - 24 Jul 2025
Viewed by 179
Abstract
Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) is a rare, often fatal congenital disorder characterized by severe neonatal respiratory distress and associated with complex multisystem malformations. In approximately 90% of cases, the condition is linked to deletions or mutations affecting the [...] Read more.
Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) is a rare, often fatal congenital disorder characterized by severe neonatal respiratory distress and associated with complex multisystem malformations. In approximately 90% of cases, the condition is linked to deletions or mutations affecting the FOXF1 gene or its upstream enhancer region on chromosome 16q24.1. This review analyzes reported prenatal cases with 16q24.1 deletion involving FOXF1, aiming to identify recurrent sonographic features and elucidate the underlying genomic and epigenetic mechanisms. We reviewed prenatal cases reported in the literature involving deletions of the 16q24.1 region, including the FOXF1 gene. Here, we expand the case series by reporting a fetus with increased nuchal translucency measuring 8 mm and a de novo 16q24.1 deletion. We identified nine prenatal cases with a 16q24.1 deletion, all involving the FOXF1 gene or its enhancer region. The main ultrasound findings included increased nuchal translucency and cystic hygroma during the first trimester, and cardiac, renal, and intestinal malformations from 20 weeks of gestation onward. Prenatal diagnosis of ACDMPV based solely on ultrasound findings is challenging. In most reported cases, the pregnancy was carried to term, with the diagnosis being confirmed by post-mortem histopathological examination. In the only case in which the pregnancy was terminated at 14 weeks’ gestation, histological examination of the fetal lungs, despite them being in the early stages of development, revealed misaligned pulmonary veins in close proximity to the pulmonary arteries and bronchioles. Evidence highlights the significance of non-coding regulatory regions in the regulation of FOXF1 expression. Differential methylation patterns, and possible contributions of parental imprinting, highlight the complexity of FOXF1 regulation. Early detection through array comparative genomic hybridization (array CGH) or next-generation sequencing to identify point mutations in the FOXF1 gene, combined with increased awareness of ultrasound markers suggestive of the condition, could improve the accuracy of prenatal diagnosis and genetic counseling. Further research into the epigenetic regulation of FOXF1 is crucial for refining recurrence risk estimates and improving genetic counseling practices. Full article
(This article belongs to the Section Human Genomics and Genetic Diseases)
Show Figures

Figure 1

11 pages, 223 KiB  
Review
Review of Foodborne Botulism in the UK: 2006–2024
by Corinne Francoise Laurence Amar, Burhan Ahmed, Jonathan Finch, Dunstan Rajendram, Vanessa K. Wong and Gauri Godbole
Foods 2025, 14(15), 2584; https://doi.org/10.3390/foods14152584 - 23 Jul 2025
Viewed by 378
Abstract
Food-borne botulism is a rare but serious disease caused by ingestion of botulinum neurotoxin pre-formed in food by Clostridium botulinum. Between 2006 and 2009, no foodborne botulism cases were reported in the UK. However, the period from 2010 to 2024 saw 13 cases, [...] Read more.
Food-borne botulism is a rare but serious disease caused by ingestion of botulinum neurotoxin pre-formed in food by Clostridium botulinum. Between 2006 and 2009, no foodborne botulism cases were reported in the UK. However, the period from 2010 to 2024 saw 13 cases, encompassing seven separate incidents and two outbreaks, with no reported fatalities. Cases were predominantly linked to imported, home-made, and artisanal foods, occasionally to commercial products. Diagnostic and public health challenges include delayed clinical diagnosis, delayed sample collection, inadequate specimen volumes, and the frequent unavailability of suspected food sources, hampering epidemiological investigations. The UK has an extremely low incidence of foodborne botulism with an estimated rate of 0.001 cases per 100,000 people per year, but despite this low occurrence, food botulism remains a public health emergency as it requires timely treatment and rapid reactive intervention to be undertaken by multiple regulatory agencies. Continuous professional training of medical staff, up-to-date clinical guidance, rapid diagnostic, and food investigations are essential for optimising patient outcomes and prevention. Full article
(This article belongs to the Special Issue Feature Reviews on Food Microbiology)
14 pages, 690 KiB  
Article
Hybrid Forecasting Framework for Emergency Material Demand in Post-Earthquake Scenarios Integrating the Grey Model and Bayesian Dynamic Linear Models
by Chenglong Chu and Guoping Huang
Sustainability 2025, 17(15), 6701; https://doi.org/10.3390/su17156701 - 23 Jul 2025
Viewed by 223
Abstract
Earthquakes are sudden and highly destructive events that severely disrupt infrastructure and logistics systems, making accurate and timely emergency material demand forecasting a critical challenge in disaster response. However, the scarcity of reliable data during the early stages of an earthquake limits the [...] Read more.
Earthquakes are sudden and highly destructive events that severely disrupt infrastructure and logistics systems, making accurate and timely emergency material demand forecasting a critical challenge in disaster response. However, the scarcity of reliable data during the early stages of an earthquake limits the effectiveness of traditional forecasting methods. To address this issue, this study proposes a hybrid forecasting framework that integrates the Grey Model (GM(1,1)) with Bayesian Dynamic Linear Models (BDLMs), aiming to improve both the accuracy and adaptability of demand predictions. The approach operates in two phases: first, GM(1,1) generates preliminary forecasts using limited initial observations; second, BDLMs dynamically update these forecasts in real time as new data become available. The model is validated through a case study of the 2010 M7.1 Yushu earthquake in Qinghai Province, China. The results indicate that the hybrid method produces reliable forecasts even at the earliest stages of the disaster, with increasing accuracy as more observational data are incorporated. Our case study demonstrates that the integrated GM(1,1)-BDLM framework substantially reduces prediction errors compared to standalone GM(1,1). Using the first five days’ data to forecast fatalities and emergency material demand for days 6–10, the hybrid model achieves a 4.01% error rate—a 19.62 percentage point improvement over GM(1,1)’s 23.63% error rate. This adaptive forecasting mechanism offers robust support for evidence-based decision-making in emergency material allocation, enhancing the efficiency and responsiveness of post-disaster relief operations. Full article
Show Figures

Figure 1

8 pages, 1550 KiB  
Case Report
Diagnostic Challenges in Acute Leukemia: From Dental Pain to Catastrophic Intracerebral Hemorrhage
by Anatoli Pinchuk, Stefan P. Roch, Christian Mawrin, Daniel Behme, Klaus-Peter Stein, Belal Neyazi, Martin Mikusko, Ibrahim Erol Sandalcioglu and Ali Rashidi
Hematol. Rep. 2025, 17(4), 36; https://doi.org/10.3390/hematolrep17040036 - 23 Jul 2025
Viewed by 151
Abstract
Background and Clinical significance: Acute leukemias are neoplasms of the hematopoietic system that are caused by the extensive proliferation of immature precursor cells (‘blasts’), mainly in the bone marrow. They frequently manifest with vague and non-specific clinical symptoms, making early diagnosis particularly [...] Read more.
Background and Clinical significance: Acute leukemias are neoplasms of the hematopoietic system that are caused by the extensive proliferation of immature precursor cells (‘blasts’), mainly in the bone marrow. They frequently manifest with vague and non-specific clinical symptoms, making early diagnosis particularly challenging. Case Presentation: This case report describes the clinical course of a female patient who initially sought dental care due to a persistent toothache—an atypical and misleading symptom. Subsequent investigations revealed a diagnosis of acute leukemia. Although the malignancy was identified promptly and the appropriate therapeutic measures were initiated, the disease progressed with alarming rapidity. The patient ultimately developed a massive intracerebral hemorrhage—a devastating complication likely related to leukemia-associated coagulopathy. Despite emergent neurosurgical intervention, the hemorrhage proved fatal. Conclusions: This case highlights the critical need for heightened clinical suspicion in the presence of unusual symptoms and illustrates the complex interplay between hematologic malignancies and coagulopathic complications. Full article
Show Figures

Figure 1

24 pages, 1694 KiB  
Article
Belgian Case Series Identifies Non-Cow Mammalian Milk Allergy as a Rare, Severe, Selective, and Late-Onset Condition
by Sophie Verelst, Robbe Sinnesael, Firoz Taïbi, Sebastian Tuyls, Lieve Coorevits, Christine Breynaert, Dominique Bullens and Rik Schrijvers
Nutrients 2025, 17(15), 2393; https://doi.org/10.3390/nu17152393 - 22 Jul 2025
Viewed by 273
Abstract
Background: Cow’s milk allergy (CMA) is the most common food allergy in children, typically resolving by adolescence. In contrast, the clinical spectrum of allergies to non-cow mammalian milk and their patterns of IgE cross-reactivity are less well documented. Nutritional differences between various [...] Read more.
Background: Cow’s milk allergy (CMA) is the most common food allergy in children, typically resolving by adolescence. In contrast, the clinical spectrum of allergies to non-cow mammalian milk and their patterns of IgE cross-reactivity are less well documented. Nutritional differences between various mammalian milks may also impact dietary management in milk-allergic patients. Objectives: To characterize clinical features, onset age, and IgE cross-reactivity patterns of non-cow mammalian milk allergies in adult patients seen at a tertiary allergy center, and to compare these findings with published cases. Methods: A retrospective analysis of patients included in the “Extended Laboratory Investigation for Rare Causes of Anaphylaxis study” with mammalian milk allergy was performed using clinical history, skin testing, and serum-specific IgE measurements. Cross-reactivity patterns were assessed in selected cases using immunoblotting, specific IgE inhibition, and basophil activation testing, and compared with published reports of non-cow mammalian milk allergy. Results: In our case series of 22 patients with mammalian milk allergy and 10 healthy control subjects, 3 patients were identified with isolated adult-onset non-cow mammalian milk allergy (n = 1 buffalo milk; n = 2 mare milk), confirmed via immunoblotting and basophil activation testing. Streptavidin-based specific IgE measurement for buffalo cheese was positive in the buffalo milk allergic patient. The literature review identified 82 cases of non-cow mammalian milk allergy. These cases typically showed late onset (mean age 8.6 years; range 1–70 years), severe reactions (CoFAR (Consortium for Food Allergy Research) grade 3 or 4 in 66%, and one fatality), and selective sensitization (affecting sheep and/or goat, camel, mare, buffalo, donkey, or combinations thereof in 56, 10, 5, 5, 4, and 2 cases, respectively). Conclusions: Non-cow mammalian milk allergies are rare but generally present later in life with selective IgE cross-reactivity, differing from the broader cross-reactivity observed in CMA. This selectivity may allow for safe dietary alternatives. These findings underscore the need for improved diagnostics and personalized dietary management in this patient population. Full article
Show Figures

Figure 1

13 pages, 1064 KiB  
Article
The Detection of Pedestrians Crossing from the Oncoming Traffic Lane Side to Reduce Fatal Collisions Between Vehicles and Older Pedestrians
by Masato Yamada, Arisa Takeda, Shingo Moriguchi, Mami Nakamura and Masahito Hitosugi
Vehicles 2025, 7(3), 76; https://doi.org/10.3390/vehicles7030076 - 20 Jul 2025
Viewed by 287
Abstract
To inform the development of effective prevention strategies for reducing pedestrian fatalities in an ageing society, a retrospective analysis was conducted on fatal pedestrian–vehicle collisions in Japan. All pedestrian fatalities caused by motor vehicle collisions between 2013 and 2022 in Shiga Prefecture were [...] Read more.
To inform the development of effective prevention strategies for reducing pedestrian fatalities in an ageing society, a retrospective analysis was conducted on fatal pedestrian–vehicle collisions in Japan. All pedestrian fatalities caused by motor vehicle collisions between 2013 and 2022 in Shiga Prefecture were reviewed. Among the 164 pedestrian fatalities (involving 92 males and 72 females), the most common scenario involved a pedestrian crossing the road (57.3%). In 61 cases (64.9%), pedestrians crossed from the oncoming traffic lane side to the vehicle’s lane side (i.e., crossing from right to left from the driver’s perspective, as vehicles drive on the left in Japan). In 33 cases (35.1%), pedestrians crossed from the vehicle’s lane side to the oncoming traffic lane side. Among cases of pedestrians crossing from the vehicle’s lane side, 54.5% were struck by the near side of the vehicle’s front, whereas 39.7% of those crossing from the oncoming traffic lane side were hit by the far side of the vehicle’s front (p = 0.02). Therefore, for both crossing directions, collisions frequently involved the front left of the vehicle. When pedestrians were struck by the front centre or front right of the vehicle, the collision speeds were higher when pedestrians crossed from the oncoming traffic lane side to the vehicle’s lane side rather than crossing from the vehicle’s lane side to the oncoming traffic lane side. A significant difference in collision speed was observed for impacts with the vehicle’s front centre (p = 0.048). The findings suggest that increasing awareness that older pedestrians may cross roads from the oncoming traffic lane side may help drivers anticipate and avoid potential collisions. Full article
(This article belongs to the Special Issue Novel Solutions for Transportation Safety)
Show Figures

Figure 1

17 pages, 363 KiB  
Systematic Review
Efficacy of GS-441524 for Feline Infectious Peritonitis: A Systematic Review (2018–2024)
by Emma Gokalsing, Joana Ferrolho, Mark S. Gibson, Hugo Vilhena and Sofia Anastácio
Pathogens 2025, 14(7), 717; https://doi.org/10.3390/pathogens14070717 - 19 Jul 2025
Viewed by 923
Abstract
Feline infectious peritonitis (FIP) is a severe viral disease with a very high fatality rate. GS-441524 is an adenosine analogue that acts as an antiviral and has shown promise in FIP treatment. However, its commercialization in some regions is not yet authorized. To [...] Read more.
Feline infectious peritonitis (FIP) is a severe viral disease with a very high fatality rate. GS-441524 is an adenosine analogue that acts as an antiviral and has shown promise in FIP treatment. However, its commercialization in some regions is not yet authorized. To evaluate the efficacy of GS-441524 based on the published literature, a systematic review was conducted. This systematic review was conducted using PubMed, ScienceDirect, and Google Scholar for studies published from 2018 onwards. Following PRISMA guidelines, 11 studies (totaling 650 FIP cases treated with GS-441524 alone or in combination) were included. Therapeutic efficacy was assessed by FIP form, clinical signs, and dosage. The overall treatment success rate was 84.6%. This rate was higher when GS-441524 was combined with other antivirals and lower in cases of wet FIP or those with neurological complications. Combination therapy with other antivirals may improve outcomes in complicated FIP cases, although further studies are needed. The GS-441524 dosages associated with the best outcomes were 5–10 mg/kg once daily (or equivalent subcutaneous dose), adjusted for FIP type, severity, and presence of neurological/ocular signs. Higher dosages can be used for severe cases or to prevent relapse, but splitting into twice-daily dosing may be necessary to avoid absorption issues. In summary, this synthesis indicates that GS-441524 is a highly promising treatment for FIP, with a high success rate among treated cases. Nevertheless, randomized controlled trials are needed to establish evidence-based therapeutic protocols tailored to different FIP presentations. Full article
Show Figures

Figure 1

12 pages, 1625 KiB  
Article
Rift Valley Fever Outbreak Investigation Associated with a Dairy Farm Abortion Storm, Mbarara District, Western Uganda, 2023
by Luke Nyakarahuka, Shannon Whitmer, Sophia Mulei, Joanita Mutesi, Jimmy Baluku, Jackson Kyondo, Amy Whitesell, Carson Telford, Alex Tumusiime, Calvin Richie Torach, Dianah Namanya, Mariam Nambuya, Dominic Muhereza, Zainah Kabami, Annet Nankya, David Muwanguzi, Francis Mugabi, Nelson Wandera, Rose Muhindo, Joel M. Montgomery, Julius J. Lutwama, Stephen Karabyo Balinandi, John D. Klena and Trevor R. Shoemakeradd Show full author list remove Hide full author list
Viruses 2025, 17(7), 1015; https://doi.org/10.3390/v17071015 - 19 Jul 2025
Viewed by 448
Abstract
In Africa, Rift Valley Fever poses a substantial risk to animal health, and human cases occur after contact with infected animals or their tissues. RVF has re-emerged in Uganda after nearly five decades, with multiple outbreaks recorded since 2016. We investigated a unique [...] Read more.
In Africa, Rift Valley Fever poses a substantial risk to animal health, and human cases occur after contact with infected animals or their tissues. RVF has re-emerged in Uganda after nearly five decades, with multiple outbreaks recorded since 2016. We investigated a unique RVF outbreak associated with an animal abortion storm of 30 events and human cases on a dairy farm in Mbarara District, Western Uganda, in February 2023. Genomic analysis was performed, comparing animal and human RVF viruses (RVFV) circulating in the region. A cluster of thirteen human RVF cases and nine PCR-positive animals could directly be linked with the abortion storm. Overall, during the year 2023, we confirmed 61 human RVFV cases across Uganda, 88.5% of which were reported to have had direct contact with livestock, and a high case fatality rate of 31%. We recommend implementing extensive health education programs in affected communities and using sustainable mosquito control strategies to limit transmission in livestock, coupled with initiating animal vaccination trials in Uganda. Full article
(This article belongs to the Special Issue Emerging Highlights in the Study of Rift Valley Fever Virus)
Show Figures

Figure 1

8 pages, 482 KiB  
Case Report
Endovascular Treatment of a Symptomatic Vertebral Artery Aneurysm in a Puerperal Patient with Neurofibromatosis Type 1—A Case Report and Review of the Literature
by Nikola Mirkovic, Marko Prokic, Nikola Prodanovic, Tamara Nikolic Turnic, Nikola Andric, Tijana Prodanovic, Neda Arsenijevic, Ivan Simic, Dragan Knezevic and Aleksandar Matic
Diseases 2025, 13(7), 226; https://doi.org/10.3390/diseases13070226 - 18 Jul 2025
Viewed by 195
Abstract
Introduction: Primary extracranial vertebral artery aneurysms are sporadic in the general population. They are uncommon in individuals with neurofibromatosis type 1. During pregnancy or in the puerperium, the risk of aneurysm rupture in individuals with neurofibromatosis type 1 and extracranial aneurysms is elevated. [...] Read more.
Introduction: Primary extracranial vertebral artery aneurysms are sporadic in the general population. They are uncommon in individuals with neurofibromatosis type 1. During pregnancy or in the puerperium, the risk of aneurysm rupture in individuals with neurofibromatosis type 1 and extracranial aneurysms is elevated. Rupture of a vertebral artery aneurysm is an emergency condition and can be fatal. Case presentation: We present the case of a 33-year-old woman in the puerperium with neurofibromatosis type 1 who had a vertebral symptomatic artery aneurysm. During a previous hospitalization, two months before the treatment of the vertebral aneurysm, a same-sided aneurysm of the thyrocervical trunk was successfully treated with endovascular coiling because of aneurysm rupture. In this case report, the vertebral artery aneurysm was successfully managed using a flow diverter stent graft. Conclusions: This is the first reported case of a successfully treated symptomatic vertebral artery aneurysm with a flow diverter stent graft in a patient with neurofibromatosis type 1 during the early puerperium. Endovascular treatment with a stent graft is a minimally invasive, safe, and effective treatment for patients with vertebral artery aneurysms. Early diagnosis of non-ruptured vertebral artery aneurysms is a crucial as well as appropriate treatment, which should be undertaken in a timely manner to prevent serious complications or a fatal outcome. Full article
Show Figures

Figure 1

13 pages, 1371 KiB  
Article
Multisite Infections Caused by Carbapenem-Resistant Klebsiella Pneumoniae: Unveiling the Clinical Characteristics and Risk Factors
by Jing Li, Shunjun Wu, Huanhuan Zhang, Xingxing Guo, Wanting Meng, Heng Zhao and Liqiang Song
Antibiotics 2025, 14(7), 721; https://doi.org/10.3390/antibiotics14070721 - 18 Jul 2025
Viewed by 350
Abstract
Objectives: There is a scarcity of studies on multisite infections (MSIs) caused by carbapenem-resistant Klebsiella pneumoniae (CRKP). The primary objectives of this research were to determine the clinical characteristics of CRKP MSI, and the risk factors of infection and mortality. Methods: [...] Read more.
Objectives: There is a scarcity of studies on multisite infections (MSIs) caused by carbapenem-resistant Klebsiella pneumoniae (CRKP). The primary objectives of this research were to determine the clinical characteristics of CRKP MSI, and the risk factors of infection and mortality. Methods: Patients with a CRKP bloodstream infection (BSI) were enrolled retrospectively between January 2017 and December 2021 in Xijing Hospital, China. The risk factors for CRKP MSI and mortality were evaluated. The demographic data, clinical and microbiological characteristics, therapy and outcomes were analyzed. Results: Among 101 patients, 74.3% (75/101) had a diagnosis of CRKP MSI, while 25.7% (26/101) of CRKP non-MSI. The overall case fatality rate was 42.6% (43/101). Multivariate analysis indicated that previous surgery (OR 3.971, 95% CI 1.504–10.480, p = 0.005) and ICU admission (OR 3.322, 95% CI 1.252–8.816, p = 0.016) were independent risk factors for CRKP MSI. ICU admission (OR 4.765, 95% CI 1.192–19.054, p = 0.027), a Pitt bacteremia score (PBS) > 4 (OR 3.820, 95% CI 1.218–11.983, p = 0.022) and thrombocytopenia (OR 8.650, 95% CI 2.573–29.007, p < 0.001) were independent risk factors for mortality due to CRKP MSI. Conclusions: Our findings confirmed that CRKP MSIs were associated with poorer outcomes. To improve prognosis, early screening of individuals at the highest risk is vital. Full article
Show Figures

Figure 1

22 pages, 652 KiB  
Review
Laboratory Diagnosis of Hendra and Nipah: Two Emerging Zoonotic Diseases with One Health Significance
by Shaun van den Hurk, Aurelle Yondo and Binu T. Velayudhan
Viruses 2025, 17(7), 1003; https://doi.org/10.3390/v17071003 - 17 Jul 2025
Viewed by 425
Abstract
Hendra virus (HeV) and Nipah virus (NiV) are two highly pathogenic RNA viruses with zoonotic potential, which can cause severe diseases with high mortality rates (50–100%) in humans and animals. Given this context, these viruses are classified as Biosafety Level 4 (BSL-4) pathogens, [...] Read more.
Hendra virus (HeV) and Nipah virus (NiV) are two highly pathogenic RNA viruses with zoonotic potential, which can cause severe diseases with high mortality rates (50–100%) in humans and animals. Given this context, these viruses are classified as Biosafety Level 4 (BSL-4) pathogens, thus limiting research studies. Despite the high case fatalities, there are currently no human vaccines available for either virus, owing in part to the limitations in research and hesitancy in funding. In the absence of widespread vaccination, diagnostic tests are crucial for the rapid identification of cases and disease surveillance. This review synthesizes current knowledge on the epidemiology, transmission dynamics, and pathogenesis of NiV and HeV to contextualize a detailed assessment of the available diagnostic tools. We examined molecular and serological assays, including RT-PCR, ELISA, and LAMP, highlighting sample sources, detection windows, and performance. Diagnostic considerations across human and animal hosts are discussed, with emphasis on outbreak applicability and field-readiness, given the need for diagnostic assays that are suitable for use in low-income areas. Further development of diagnostic assays, including isothermal amplification tests and other next-generation approaches, is recommended to fill the gap in rapid, point-of-care diagnostics. Full article
(This article belongs to the Section Human Virology and Viral Diseases)
Show Figures

Figure A1

Back to TopTop